ATE328327T1 - Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays - Google Patents

Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays

Info

Publication number
ATE328327T1
ATE328327T1 AT00947001T AT00947001T ATE328327T1 AT E328327 T1 ATE328327 T1 AT E328327T1 AT 00947001 T AT00947001 T AT 00947001T AT 00947001 T AT00947001 T AT 00947001T AT E328327 T1 ATE328327 T1 AT E328327T1
Authority
AT
Austria
Prior art keywords
thrombosis
presenting
unknown sample
assay data
data
Prior art date
Application number
AT00947001T
Other languages
English (en)
Inventor
Thomas B Givens
Paul Braun
Lisa Beck
Original Assignee
Bio Merieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux Inc filed Critical Bio Merieux Inc
Application granted granted Critical
Publication of ATE328327T1 publication Critical patent/ATE328327T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/224—Haemostasis or coagulation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT00947001T 1999-06-30 2000-06-30 Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays ATE328327T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/345,080 US6502040B2 (en) 1997-12-31 1999-06-30 Method for presenting thrombosis and hemostasis assay data

Publications (1)

Publication Number Publication Date
ATE328327T1 true ATE328327T1 (de) 2006-06-15

Family

ID=23353417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947001T ATE328327T1 (de) 1999-06-30 2000-06-30 Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays

Country Status (10)

Country Link
US (1) US6502040B2 (de)
EP (1) EP1188060B1 (de)
JP (1) JP2003529046A (de)
KR (1) KR20020042539A (de)
AT (1) ATE328327T1 (de)
AU (1) AU768436B2 (de)
CA (1) CA2377528C (de)
DE (1) DE60028374T2 (de)
ES (1) ES2270850T3 (de)
WO (1) WO2001001152A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1436628A2 (de) * 2001-06-29 2004-07-14 BioMerieux, Inc. Verfahren zur vorhersage einer erhöhten wahrscheinlichkeit für antiphospholipidsyndrom in einem patienten
WO2003063929A1 (en) * 2002-01-28 2003-08-07 Debiotech S.A. Peritoneal dialysis system
US9125989B2 (en) 2003-01-23 2015-09-08 Debiotech S.A. Device for determining the characteristics of peritoneal membrane
ES1063877Y (es) 2006-10-02 2007-03-16 Lafuente Flo Rosa Funda perfeccionada para cascos de motocicleta
AU2009213995B2 (en) * 2008-02-14 2014-05-22 Orion Diagnostica Oy Method for predicting a future property
WO2009135205A2 (en) * 2008-05-02 2009-11-05 Advanced Liquid Logic, Inc. Droplet actuator techniques using coagulatable samples
WO2009142744A2 (en) * 2008-05-20 2009-11-26 The University Of Vermont And State Agriculture College Predicting hemostatic risk; dependence on plasma composition
JP5982976B2 (ja) * 2012-04-13 2016-08-31 ソニー株式会社 血液凝固系解析装置、血液凝固系解析方法及びそのプログラム

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3307392A (en) 1964-05-04 1967-03-07 Research Corp Automatic prothrombin timer apparatus and method
US3458287A (en) 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3658480A (en) 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US4047890A (en) 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
SU590665A1 (ru) 1976-02-11 1978-01-30 Новосибирский государственный медицинский институт Способ исследовани процесса свертывани крови
US4040788A (en) 1976-04-05 1977-08-09 Sanford L. Simons Apparatus, instrumentation, and method for comparing samples
DE2635081C3 (de) 1976-08-04 1980-08-07 Bio/Data Corp., Willow Grove, Pa. (V.St.A.) Verfahren und Vorrichtung zur Bestimmung von Blutplasma-Gerinnungsfaktorpegeln
FR2364453A1 (fr) 1976-09-08 1978-04-07 Lacombe Pierre Dispositif electronique apportant un perfectionnement aux appareils destines a analyser la coagulation sanguine : prothrombinometre citrate-oxalate
US4199748A (en) 1976-11-01 1980-04-22 Rush-Presbyterian-St. Luke's Medical Center Automated method and apparatus for classification of cells with application to the diagnosis of anemia
JPS5451893A (en) 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
JPS5822703B2 (ja) 1978-08-30 1983-05-10 三共株式会社 血液凝固測定方法
US4289498A (en) 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4766083A (en) 1982-04-04 1988-08-23 Wako Pure Chemical Industries, Ltd. Method for the photometric determination of biological agglutination
SU1076086A1 (ru) 1982-12-28 1984-02-29 Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники Гемокоагулограф
EP0115459A3 (de) 1983-01-26 1986-11-20 University Of Medicine And Dentistry Of New Jersey Haematologische Voraussage von Sepsis und anderen erkrankten Zuständen
US4705756A (en) 1983-01-26 1987-11-10 University Of Medicine And Dentistry Of New Jersey Method of determining the existence and/or the monitoring of a pathological condition in a mammal
JPS59203959A (ja) 1983-05-04 1984-11-19 Toa Medical Electronics Co Ltd 血液凝固時間測定装置
JPH0695095B2 (ja) 1983-11-25 1994-11-24 株式会社島津製作所 全自動血液分析装置
DE3502878A1 (de) 1985-01-29 1986-07-31 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung des fibrinolytischen zustands von plasma
JPS61272655A (ja) 1985-05-28 1986-12-02 Iryo Kogaku Kenkyusho:Kk 血小板凝集能の定量的判定方法
GB8516081D0 (en) 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
US4902630A (en) 1985-07-22 1990-02-20 Abbott Laboratories Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein
ATE134880T1 (de) 1988-04-04 1996-03-15 Lawrence A Potempa Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
US5593897A (en) 1988-04-04 1997-01-14 Northwestern University Binding of immune complexes by modified forms of C-reactive protein
US4965725B1 (en) 1988-04-08 1996-05-07 Neuromedical Systems Inc Neural network based automated cytological specimen classification system and method
US5156974A (en) 1988-05-27 1992-10-20 Biodata Corporation Method for determining the fibrinogen level of a blood sample
US5003065A (en) 1988-06-14 1991-03-26 Carey Merritt Compounds and process for measuring c-reactive protein
US5697369A (en) * 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
US5055412A (en) 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
US5500345A (en) 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
AU642430B2 (en) 1989-06-27 1993-10-21 Rush - Presbyterian - St. Luke's Medical Center Monoclonal antibodies to c-reactive protein
WO1991001383A1 (en) 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
US5051357A (en) 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
DE69033033T2 (de) 1989-07-20 1999-10-28 Analytical Control Systems, Inc. Verbesserte kontrollverfahren für stabile blutkoagulation
SU1691741A1 (ru) 1989-08-25 1991-11-15 Донецкий государственный медицинский институт Способ прогнозировани геморрагических осложнений при травматической болезни
US4998535A (en) 1989-09-05 1991-03-12 Univ. of Washington New England Medical Center Hospitals, Inc. Thrombolysis predictive instrument
US5262303A (en) 1989-10-13 1993-11-16 Trustees Of Boston University Ligand/anti-ligand assays for adherent proteins
IE904244A1 (en) 1989-12-01 1991-06-05 Akzo Nv Direct fibrinogen assay
US5646046A (en) 1989-12-01 1997-07-08 Akzo Nobel N.V. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5169786A (en) 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
DE69120674T2 (de) 1990-04-17 1996-11-07 Analytical Control Syst Inc Koagulationsassays und reagenzien
US5862304A (en) 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
US5218529A (en) 1990-07-30 1993-06-08 University Of Georgia Research Foundation, Inc. Neural network system and methods for analysis of organic materials and structures using spectral data
JPH04254760A (ja) 1991-01-30 1992-09-10 Eiken Chem Co Ltd 血清アミロイドａ標準物質、およびその設定方法
US5221628A (en) 1991-03-19 1993-06-22 Northwestern University Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component
RU2012877C1 (ru) 1991-04-01 1994-05-15 Белорусский научно-исследовательский институт охраны материнства и детства Способ прогнозирования синдрома дыхательных расстройств у недоношенных новорожденных
ES2094212T3 (es) 1991-08-02 1997-01-16 Grifols Grupo Sa Procedimiento y aparato para la determinacion del tiempo de coagulacion de la sangre y del plasma.
JPH0559415A (ja) * 1991-09-02 1993-03-09 Kobe Steel Ltd 高炉炉熱変化推定装置
WO1993007491A1 (en) 1991-10-04 1993-04-15 Board Of Regents Of The University Of Nebraska A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
US5716795A (en) 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
EP0642667B1 (de) 1991-11-04 2001-01-10 Adeza Biomedical Corporation Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko
JPH05180835A (ja) 1991-12-27 1993-07-23 S R L:Kk ループスアンチコアグラントの測定方法
US5318958A (en) 1992-05-29 1994-06-07 Queen's University At Kingston Amyloid precursor protein
JP2934557B2 (ja) 1992-07-10 1999-08-16 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH0636061A (ja) 1992-07-21 1994-02-10 Fujitsu Ltd 階層型ニューラルネットワークの学習方式
DE4224621C2 (de) * 1992-07-25 1994-05-05 Boehringer Mannheim Gmbh Verfahren zur Analyse eines Bestandteils einer medizinischen Probe mittels eines automatischen Analysegerätes
US5388164A (en) 1992-08-19 1995-02-07 Olympus Optical Co., Ltd. Method for judging particle agglutination patterns using neural networks
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
US5369484A (en) 1992-11-09 1994-11-29 Akzo N.V. Multiple discrete analyzer test apparatus and method
US5358852A (en) 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
RU2070327C1 (ru) 1992-12-25 1996-12-10 Безруков Александр Васильевич Устройство для измерения времени свертывания крови
US5344754A (en) 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
JP2938302B2 (ja) 1993-02-25 1999-08-23 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH06249857A (ja) 1993-02-26 1994-09-09 Hitachi Ltd 自動分析装置
RU2061953C1 (ru) 1993-03-10 1996-06-10 Тюменский государственный медицинский институт МЗ РФ Способ количественного определения общей коагуляционной активности тромбоцитов
US5670329A (en) 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
EP0714506B1 (de) 1993-08-16 2004-11-10 bioMérieux, Inc. Methode und gerät zur automatischen durchführung von analysen bezüglich thrombose und blutgerinnung
US5526111A (en) 1993-08-31 1996-06-11 Boehringer Mannheim Corporation Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control
US5472852A (en) 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US5473732A (en) 1993-11-02 1995-12-05 Chang; Hou-Mei H. Relational artificial intelligence system
US5553616A (en) 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US5856114A (en) * 1994-03-21 1999-01-05 The University Of Vermont Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings
AU696924B2 (en) 1994-04-28 1998-09-24 Dade Behring Inc. Calibrator for prothrombin time (PT) assays
WO1996006624A1 (en) 1994-08-26 1996-03-07 Immtech International, Inc. A mutant protein and methods and materials for making and using it
US5504011A (en) 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
SE9403833D0 (sv) 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysförfarande och kit
US5705395A (en) 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US5567596A (en) 1994-12-29 1996-10-22 Research Foundation Of State University Of New York Rapid assay of activators and inhibitors of clotting
EP0802986B1 (de) 1995-01-10 2001-09-19 Hendrik Coenraad Hemker Verfahren zum nachweis des endogenen thrombin-potentials und thrombin substrate zur verwendung in diesen verfahren
US5708591A (en) 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US5780255A (en) 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
JPH11510596A (ja) 1995-07-21 1999-09-14 ザ・プロヴォスト，フェローズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホーリー・アンド・アンディヴァイデッド・トリニティー・オブ・クイーン・エリザベス・ニアー・ダブリン ヒト急性期血清アミロイドａタンパク質、組換えタンパク質、特異的抗体の定量的測定法
US5766869A (en) 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
EP0827425B1 (de) 1996-03-22 2004-11-03 Dade Behring Inc. Kombinierte reagenzaufnahme- und testanordnung
JPH1026621A (ja) 1996-07-12 1998-01-27 Dai Ichi Pure Chem Co Ltd イムノアッセイ法
US5684007A (en) 1996-09-05 1997-11-04 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
JP3876022B2 (ja) 1996-09-26 2007-01-31 生化学工業株式会社 血液凝固時間に影響を与える物質の定量方法
WO2000007012A1 (en) 1998-07-31 2000-02-10 Carroll Wallace E Method and apparatus for determining anticoagulant therapy factors
EP0841566A1 (de) 1996-11-11 1998-05-13 Pentapharm A.G. Positivkontrollplasma für den Lupus-Antikoagulant-Nachweiser
DK1493439T3 (da) 1997-04-02 2012-01-30 Brigham & Womens Hospital Middel til fastlæggelse af en persons risikoprofil for aterosklerotisk sygdom
US6010911A (en) 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
DK0947585T3 (da) 1998-03-19 2001-10-01 Instrumentation Lab Spa Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter

Also Published As

Publication number Publication date
US20020010553A1 (en) 2002-01-24
WO2001001152A9 (en) 2002-05-02
US6502040B2 (en) 2002-12-31
EP1188060B1 (de) 2006-05-31
JP2003529046A (ja) 2003-09-30
EP1188060A1 (de) 2002-03-20
ES2270850T3 (es) 2007-04-16
DE60028374D1 (de) 2006-07-06
DE60028374T2 (de) 2007-06-06
CA2377528C (en) 2008-02-05
KR20020042539A (ko) 2002-06-05
AU768436B2 (en) 2003-12-11
WO2001001152A1 (en) 2001-01-04
AU6067600A (en) 2001-01-31
EP1188060A4 (de) 2005-04-13
CA2377528A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
DE69719057D1 (de) Verfahren zur signalverstärkung
DE69429770D1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
ATE253645T1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
DE69631483T2 (de) Detektion von fehlerhaften basenpaarungen durch spaltung mittels resolvase wobei magnetische kügelchen verwendet werden
DE69227379D1 (de) Verfahren und Reagenzien zur Bestimmung von Bakterien in der zerebrospinalen Flüssigkeit
DE69513248D1 (de) Zusammensetzung, Verfahren und System zum Nachweis von Leukocyten, Esterasen oder Proteasen in einer Testprobe
ATE262178T1 (de) Identifizierung und charakterisierung von interagierenden molekülen
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
DE59814441D1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
DE69918123D1 (de) Verfahren und reagentiensatz zur erkennung von protein-protein wechselwirkungen
ATE328327T1 (de) Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays
DE59510255D1 (de) Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
ATE313082T1 (de) Verfahren zum betreiben von unterschiedlichen geräten zur durchführung eines prozesses
DE60202008D1 (de) Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
ATE226322T1 (de) Verfahren zum durchführen von bluttests
ATE221657T1 (de) Entstörung durch rheumafaktoren
DE69728665D1 (de) Verfahren und sets zur detektion von endotoxinen
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
DE69309760D1 (de) Kolorimetrische Methoden und Reagenzien zum Nachweis von Calcium in einer Testprobe
DE68916773D1 (de) Verfahren und Anordnung zur Detektion von Übermodulation für die Signalanalyse.
DE50208262D1 (de) Verfahren zur bestimmung von flüchtigen substanzen in lösung
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
KR890006828A (ko) 효소 분석법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties